Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 12.10
-0.35 (-2.81%)
May 29, 2026, 1:37 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.18 billion as of May 29, 2026. Its market cap has decreased by -13.22% in one year.
Market Cap
1.18B
Enterprise Value
2.08B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.10
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.18B, a decrease of -39.59%. That is a compound annual growth rate of -15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.18B | -18.26% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Andros Pharmaceuticals Co.,Ltd | 1.37B |
| NeoCore Technology | 1.34B |
| Abnova (Taiwan) | 1.27B |
| Enimmune | 1.26B |
| BiOptic | 1.17B |
| LabTurbo Biotech | 1.10B |
| Level Biotechnology | 1.09B |
| Holy Stone Healthcare | 1.06B |